Navigating Your Semaglutide Journey: What Dose Do You Start With?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Beginning semaglutide therapy requires a thoughtful approach to dosing that balances effectiveness with tolerability. Most individuals start at a subclinical dose designed to minimize side effects while your metabolism adjusts to this GLP-1 receptor agonist. PlexusDx personalizes your starting protocol based on your unique physiology, ensuring you begin at the right place on your weight loss journey.

Why Semaglutide Dosing Starts Low and Builds Gradually

Semaglutide works by signaling to your brain's appetite centers and slowing stomach emptying, but these powerful effects require a gradual introduction. Starting at a lower dose allows your gastrointestinal system and metabolic pathways to adapt without overwhelming your system. This titration schedule, typically increasing every 4 weeks, helps your body develop tolerance while maximizing long-term adherence and comfort.

Clinical experience shows that patients who begin at appropriately conservative doses experience better medication persistence over time. Your initial dose is not your final dose—instead, it represents the foundation of a personalized escalation plan. PlexusDx tailors this progression based on your tolerance signals and clinical goals, ensuring steady progress toward sustainable weight management.

Understanding Your Individual Starting Point

Not everyone begins semaglutide at identical starting doses because body composition, metabolic health, and gastrointestinal sensitivity vary significantly between individuals. Some people tolerate an initial dose without difficulty, while others benefit from an even gentler introduction. Your healthcare provider considers your baseline weight, kidney function, prior medication responses, and specific health conditions when determining where you begin.

PlexusDx uses comprehensive health intake and optional genetic testing through the Precision Peptide Genetic Test to identify your genetic predispositions in appetite regulation pathways. Variants in genes like MC4R rs17782313 can influence how your body responds to semaglutide signaling. This genetic insight, combined with clinical assessment, helps establish a starting dose aligned with your biology rather than a one-size-fits-all approach.

The Four-Week Titration Schedule

A typical semaglutide titration spans 4 weeks between dose increases, allowing your body sufficient time to adapt and for you to accurately report how you're responding. During each 4-week period, you remain on the same dose while monitoring appetite suppression, energy levels, gastrointestinal tolerance, and weight trends. This structured timeline gives your clinical team clear data points to decide whether to advance your dose or hold steady.

Most individuals reach therapeutic doses within 8–12 weeks, though some benefit from a slower progression if side effects emerge. Common early effects include mild nausea or reduced appetite, which typically diminish as your body adjusts. If bothersome symptoms persist, your PlexusDx provider can extend the interval between increases, adjust your dose progression, or modify concurrent medications to support your comfort while maintaining efficacy.

How Genetics and Personalization Shape Your Dosing Plan

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx uses your genetic profile to forecast your personalized dose trajectory and refine your titration schedule before starting therapy. This proactive approach means your starting dose and progression plan already account for your body's unique biochemistry. Combined with real-time clinical monitoring, this genetic-informed model reduces guesswork and accelerates your path to sustainable weight loss while keeping your monthly cost flat at $149—regardless of which dose tier you reach.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is a typical starting dose of semaglutide for weight loss?

Most individuals begin semaglutide at 0.25 mg once weekly, a subclinical priming dose that introduces your body to the medication with minimal side effects. This first dose allows your GLP-1 receptors and appetite pathways to acclimate before advancing every 4 weeks. PlexusDx personalizes this starting point based on your health profile and genetic predispositions to ensure optimal tolerability and efficacy.

How long does it take to reach the full therapeutic dose?

Reaching a therapeutic maintenance dose typically requires 8–12 weeks of progressive increases, though individual timelines vary based on tolerance and response. Standard titration advances by 0.25 mg weekly increments every 4 weeks until reaching your target (often 2.4 mg weekly for semaglutide injection). Your PlexusDx provider monitors your progress and adjusts the pace if needed to balance efficacy with comfort.

Does my price increase as my dose increases with PlexusDx?

No. PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains flat regardless of which dose level you reach—your dose may increase, but your price won't. This transparent, commitment-tier pricing means you can advance to your optimal therapeutic dose without worrying about escalating monthly costs. HSA and FSA funds are eligible for use.

What side effects should I expect during dose titration?

Early side effects commonly include mild nausea, reduced appetite, and occasional constipation, typically appearing 2–4 days after injection and subsiding within a few days as your body adapts. These effects usually diminish significantly by week 4 as your tolerance builds. Severe or persistent side effects warrant contact with your PlexusDx provider, who can extend your titration timeline or adjust your dosing schedule to improve comfort.

How does the Precision Peptide Genetic Test help with my starting dose?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide Starting Dose
• What Is Genetic Peptide Testing And Why It Matters Before You Start A Protocol
• Medvi Semaglutide
• Bioverse Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.